Incidence of hypermucoviscous Klebsiella pneumoniae and phenotypic detection of their virulence factors along with classical strains among patients visiting tertiary care hospital
DOI:
https://doi.org/10.3855/jidc.19456Keywords:
Klebsiella pneumoniae, hypermucoviscosity, multi-drug resistance, biofilm, serum resistanceAbstract
Introduction: A new strain of Klebsiella pneumoniae named hypermucoviscous K. pneumoniae emerges with a distinctive feature to classical strains. Infections due to hypermucoviscous strains have increased with significant mortality and morbidity. This study aimed to determine the prevalence of hypermucoviscous K. pneumoniae and compare their virulence with the classical strains phenotypically.
Methodology: One hundred-five clinical isolates of K. pneumoniae isolates proceeded for the study. A modified string test evaluated the hypermucoviscosity. The determination of antibiotic susceptibility was done using the Kirby-Bauer disk diffusion method. A phenotypic combination disk test was used to detect β-lactamases (ESBL, MBL, and KPC). Serum resistance was determined by the viable count method, and biofilm production by the microtiter plate method.
Results: The modified string test detected 27.6% (29/105) of isolates as hypermucoviscous and 72.4% (76/105) as classical K. pneumoniae. Most K. pneumoniae were resistant to ceftazidime (80%) and cefotaxime (78%), and 46.7% were resistant to both imipenem and meropenem. A combination disk test identified 53.3% of ESBL, 28.6% of MBL, and 17.2% of KPC producers. Furthermore, 24.8% of K. pneumoniae were biofilm producers, and 39% were found to be serum resistant.
Conclusions: In comparison, classical strains were more likely to develop ESBL, MBL, KPC, and biofilms while hypermucoviscous strains have higher serum resistance. The present study revealed that hypermucoviscous K. pneumoniae strains are prevalent and can be associated with metastatic invasive infections. Therefore, appropriate treatment strategies and timely diagnosis of these strains to limit their infection are crucial.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Tika Bahadur Thapa, Sujina Maharjan, Nisha Giri, Manisha Sapkota, Ojaswee Shrestha, Puspa Raj Khanal, Govardhan Joshi

This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).

